1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Global Active Pharmaceutical Ingredient Market: Product Outlook
4. Global Active Pharmaceutical Ingredient Market: Size and Forecast
4.1 Global Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026
Table 1: Global Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
Table 2: Percentage of API manufacturing facilities for all drugs (August 2019)
Table 3: Worlds leading causes of death (in millions), 2019
Table 4: World Population 65 Years & Above (% of Total), 2015-2019
Table 5: Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 6: Estimated number of new cases in 2020, worldwide, both sexes, all ages
5. Global Active Pharmaceutical Ingredient Market Segmentation By Application, By Drug Type, By Synthesis
5.1 Competitive Scenario of Global Active Pharmaceutical Ingredient Market: By Application
Table 7: Global Active Pharmaceutical Ingredient Market-By Application Market Share, 2020 & 2026
5.1.1 Oncology Market Size and Forecast (2016-2026)
Table 8: Global Active Pharmaceutical Ingredient Market- By Oncology, By Value (USD Billion), 2016-2026
5.1.2 Cardiology Market Size and Forecast (2016-2026)
Table 9: Global Active Pharmaceutical Ingredient Market- By Cardiology, By Value (USD Billion), 2016-2026
5.1.3 Diabetes Market Size and Forecast (2016-2026)
Table 10: Global Active Pharmaceutical Ingredient Market- By Diabetes, By Value (USD Billion), 2016-2026
5.1.4 Neurology Market Size and Forecast (2016-2026)
Table 11: Global Active Pharmaceutical Ingredient Market- By Neurology, By Value (USD Billion), 2016-2026
5.1.5 Others Market Size and Forecast (2016-2026)
Table 12: Global Active Pharmaceutical Ingredient Market- By Others, By Value (USD Billion), 2016-2026
5.2 Competitive Scenario of Global Active Pharmaceutical Ingredient Market: By Drug Type
Table 13: Global Active Pharmaceutical Ingredient Market- By Drug Type Market Share, 2020 & 2026
5.2.1 Generic API Market Size and Forecast (2016-2026)
Table 14: Global Active Pharmaceutical Ingredient Market- By Generic API, By Value (USD Billion), 2016-2026
5.2.2 Innovative API Market Size and Forecast (2016-2026)
Table 15: Global Active Pharmaceutical Ingredient Market- By Innovative API, By Value (USD Billion), 2016-2026
5.3 Competitive Scenario of Global Active Pharmaceutical Ingredient Market: By Synthesis
Table 16: Global Active Pharmaceutical Ingredient Market- By Synthesis Market Share, 2020 & 2026
5.3.1 Synthetic Market Size and Forecast (2016-2026)
Table 17: Global Active Pharmaceutical Ingredient Market- By Synthetic, By Value (USD Billion), 2016-2026
5.3.2 Biotech Market Size and Forecast (2016-2026)
Table 18: Global Active Pharmaceutical Ingredient Market- By Biotech, By Value (USD Billion), 2016-2026
6. Global Active Pharmaceutical Ingredient Market: Regional Analysis
6.1 Competitive Scenario of Global Active Pharmaceutical Ingredient Market : By Region
Table 19: Global Active Pharmaceutical Ingredient Market- By Region Market Share, 2020 & 2026
7. North America Active Pharmaceutical Ingredient Market: An Analysis (2016-2026)
7.1 North America Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
Table 20: North America Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
Table 21: North America Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Table 22: North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 23: North America Urban population, 2015-2018 (In %)
7.2 North America Active Pharmaceutical Ingredient Market Prominent Companies
Table 24: North America Active Pharmaceutical Ingredient players market share (%), 2020
7.3 Market Segmentation By Application (Oncology, Cardiology, Diabetes, Neurology and Others)
Table 25: North America Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
7.4 Market Segmentation By Drug Type (Generic API and Innovative API)
Table 26: North America Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
7.5 Market Segmentation By Synthesis (Synthetic and Biotech)
Table 27: North America Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
7.6 North America Active Pharmaceutical Ingredient Market: Country Analysis
7.7 Market Opportunity Chart of North America Active Pharmaceutical Ingredient Market - By Country, By Value, 2026
Table 28: Market Opportunity Chart of North America Active Pharmaceutical Ingredient Market- By Country, By Value (Year 2016-2026)
7.8 Competitive Scenario of North America Active Pharmaceutical Ingredient Market: By Country
Table 29: North America Active Pharmaceutical Ingredient Market- By Country Market Share, 2020 & 2026
7.9 United States Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
Table 30: United States Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
Table 31: United States year-on-year growth of Active Pharmaceutical Ingredient (in %), (2017-2026)
Table 32: United States population aged 65 and above, (in % of the total population), 2016-2020
Table 33: United States health expenditure (% of GDP), 2013-2018
7.10 United States Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
Table 34: United States Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
Table 35: United States Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
Table 36: United State Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
7.11 Canada Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
Table 37: Canada Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
Table 38: Canada population aged 65 and above (% of total population), 2016-2020
Table 39: Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 40: Canada Urban population, 2015-2019 (In %)
7.12 Canada Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
Table 41: Canada Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
Table 42: Canada Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
Table 43: Canada Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
8. Europe Active Pharmaceutical Ingredient Market: Segmentation (By Application, By Drug Type, By Synthesis)
8.1 Europe Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
Table 44: Europe Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
Table 45: Europe current health expenditure (% of GDP), (2014-2018)
Table 46: Europe population aged 65 and above (% of the total population), 2020
Table 47: Europe percentage of dying between age 30 to 70 from any cardiovascular disease, cancer, diabetes and chronic respiratory disease, 2019
8.2 Europe Active Pharmaceutical Ingredient Market Prominent Companies
Table 48: Europe Active Pharmaceutical Ingredient players market share (%), 2020
8.3 Market Segmentation By Application (Oncology, Cardiology, Diabetes, Neurology and Others)
Table 49: Europe Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
8.4 Market Segmentation By Drug Type (Generic API and Innovative API)
Table 50: Europe Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
8.5 Market Segmentation By Synthesis (Synthetic and Biotech)
Table 51: Europe Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
8.6 Europe Active Pharmaceutical Ingredient Market: Country Analysis
8.7 Market Opportunity Chart of Europe Active Pharmaceutical Ingredient Market - By Country, By Value, 2026
Table52: Market Opportunity Chart of Europe Active Pharmaceutical Ingredient Market- By Country, By Value (2016-2026)
8.8 Competitive Scenario of Europe Active Pharmaceutical Ingredient Market: By Country
Table53: Europe Active Pharmaceutical Ingredient Market- By Country Market Share, 2020 & 2026
8.9 Germany Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
Table 54: Germany Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
Table 55: Germany current health expenditure (% of GDP), (2014-2018)
Table 56: Germany population aged 65 and above (% of the total population), 2016-2020
Table 57: Germany urban population (% of the total population), 2016-2019
8.10 Germany Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
Table 58: Germany Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
Table 59: Germany Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
Table 60: Germany Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
8.11 United Kingdom Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
Table 61: United Kingdom Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
Table 62: United Kingdom current health expenditure (% of GDP), (2014-2018)
Table 63: United Kingdom population aged 65 and above (% of the total population), 2016-2020
Table 64: United Kingdom urban population (in millions), 2016-2020
8.12 United Kingdom Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
Table 65: United Kingdom Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
Table 66: United Kingdom Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
Table 67: United Kingdom Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
8.13 France Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
Table 68: France Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
Table 69: France current health expenditure (% of GDP), (2014-2018)
Table 70: France urban population (% of total population), 2016-2020
Table 71: France population aged 65 and above (% of total population), 2016-2020
8.14 France Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
Table 72: France Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
Table 73: France Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
Table 74: France Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
8.15 Spain Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
Table 75: Spain Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
Table 76: Spain current health expenditure (% of GDP), (2014-2018)
Table 77: Spain population aged 65 and above (% of total population), 2016-2020
Table 78: Spain urban population (% of total population), 2016-2020
8.16 Spain Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
Table 79: Spain Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
Table 80: Spain Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
Table 81: Spain Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
8.17 Italy Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
Table 82: Italy Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
Table 83: Italy current health expenditure (% of GDP), (2014-2018)
Table 84: Italy population aged 65 and above (% of total population), 2016-2020
Table 85: Italy urban population (% of total population), 2016-2020
8.18 Italy Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
Table 86: Italy Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
Table 87: Italy Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
Table 88: Italy Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
9. Asia Pacific Active Pharmaceutical Ingredient Market: An Analysis (2016-2026)
9.1 Asia Pacific Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
Table 89: Asia Pacific Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
Table 90: Asia Pacific urban population (% of the total population), 2016-2020
Table 91: Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 92: Asia Pacific population aged 65 years and above (% of the total population), 2016-2020
9.2 Asia Pacific Active Pharmaceutical Ingredient Market Prominent Companies
9.3 Market Segmentation By Application (Oncology, Cardiology, Diabetes, Neurology and Others)
Table 93: Asia Pacific Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
9.4 Market Segmentation By Drug Type (Generic API and Innovative API)
Table 94: Asia Pacific Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
9.5 Market Segmentation By Synthesis (Synthetic and Biotech)
Table 95: Asia Pacific Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
9.6 Asia Pacific Active Pharmaceutical Ingredient Market: Country Analysis
9.7 Market Opportunity Chart of Asia Pacific Active Pharmaceutical Ingredient Market - By Country, By Value, 2026
Table 96: Market Opportunity Chart of APAC Active Pharmaceutical Ingredient Market- By Country, By Value (Year-2026)
9.8 Competitive Scenario of Asia Pacific Active Pharmaceutical Ingredient Market: By Country
Table 97: APAC Active Pharmaceutical Ingredient Market- By Country Market Share, 2020 & 2026
9.9 China Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
Table 98: China Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
Table 99: China total population in billions, 2016-2020
Table 100: China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 101: China export destinations of Active Pharmaceutical Ingredient, 2019
9.10 China Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
Table 102: China Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
Table 103: China Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
Table 104: China Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
9.11 Japan Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
Table 105: Japan Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
Table 106: Japan population above 65 years (% of the total population), 2016-2020
Table 107: Japan Current Healthcare Expenditure as a percentage of GDP, 2015-2018 (In %)
Table 108: Japan urban population (in millions), 2016-2020
9.12 Japan Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
Table 109: Japan Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
Table 110: Japan Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
Table 111: Japan Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
9.13 India Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
Table 112: India Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
Table 113: India Current Healthcare Expenditure (% of GDP), 2015-2018
Table 114: India population (in billions), 2016-2020
Table 115: India urban population (% of total population), 2015-2019
9.14 India Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
Table116: India Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
Table117: India Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
Table118: India Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Million), 2016-2026
10. Global Active Pharmaceutical Ingredient Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market By Application, 2026
Table 119: Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market- By Application (Year-2016-2026)
11.2 Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market - By Drug Type, 2026
Table 120: Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market- By Drug Type (Year 2016-2026)
11.3 Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market - By Synthesis, 2026
Table 121: Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market- By Synthesis (Year 2016-2026)
11.4 Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market - By Region, 2026
Table 122: Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market- By Region (Year 2016-2026)
12. Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.3 Market Share Analysis
Table123: Global Active Pharmaceutical Ingredient players market share (%), 2020
13. Company Analysis
13.1 Pfizer Inc.,
Table 124: Pfizer Inc., Annual Sales Revenue (USD Million), 2016-2020
Table 125: Pfizer Inc., Annual Net Income/Loss (USD Million), 2016-2020
Table 126: Pfizer Inc., sales Revenue, By Geographical Segment (%), FY2020
13.2 GlaxoSmithKline
Table 127: GlaxoSmithKline Annual Sales Revenue (USD Million), 2016-2020
Table 128: GlaxoSmithKline Gross Profit (USD Million), 2016-2020
Table 129: GlaxoSmithKline Sales Revenue Split, By Business Segment (%), FY2020
Table 130: GlaxoSmithKline Sales Revenue Split, By Geography Segment (%), FY2020
13.3 AbbVie Inc.
Table 131: AbbVie Inc. Annual Sales Revenue (USD Million), 2016-2020
Table 132: AbbVie Inc. Net Income (USD Million), 2016-2020
Table 133: AbbVie Inc. Sales Revenue Split, By Business Segment (%), FY2020
Table 134: AbbVie Inc. Sales Revenue Split, By Geography Segment (%), FY2020
13.4 Novartis AG
Table 135: Novartis Annual Sales Revenue (USD Million), 2016-2020
Table 136: Novartis Annual Net Income/Loss (USD Million), 2016-2020
Table 137: Novartis Sales Revenue Split, By Business Segment (USD Million), FY2020
Table 138: Novartis Sales Revenue Split, By Geography Segment (%), FY2020
13.5 Eli Lilly and Company
Table 139: Eli Lilly and Company Annual Sales Revenue (USD Million), 2016-2020
Table 140: Eli Lilly and Company Annual Net Income (USD Million), 2016-2020
Table 141: Eli Lilly and Company Sales Revenue Split, By Business Segment (USD Million), FY2020
Table 142: Eli Lilly and Company Sales Revenue Split, By Geography Segment (%), FY2020
13.6 Merck KGaA
Table 143: Merck KGaA Sales Revenues, 2016-2020 (USD Million)
Table 144: Merck KGaA Gross Profit, 2016-2020 (USD Million)
Table 145: Merck KGaA Sales Revenue Split, By Business Segment (%), FY2020
Table 146: Merck KGaA Sales Revenue Split, By Geography Segment (%), FY2020
13.7 Teva Pharmaceutical Industries Ltd.
Table 147: Teva Pharmaceutical Industries Ltd. Sales Revenues, 2016-2020 (USD Million)
Table 148: Teva Pharmaceutical Industries Ltd. Net Income, 2016-2020 (USD Million)
Table 149: Teva Pharmaceutical Industries Ltd. sales Revenues, By Business Segment (%) in North America, FY2020
Table 150: Teva Pharmaceutical Industries Ltd. sales Revenue, By Geographical Segment (%), FY2020
13.8 Sanofi
Table 151: Sanofi Sales Revenues, 2016-2020 (USD Million)
Table 152: Sanofi Gross Profit, 2016-2020 (USD Million)
Table 153: Sanofi Sales Revenue Split, By Business Segment (%), FY2020
Table 154: Sanofi Sales Revenue Split, By Geography Segment (%), FY2020
13.9 Bristol-Myers Squibb
Table 155: Bristol-Myers Squibb Sales Revenues, 2016-2020 (USD Million)
Table 156: Bristol-Myers Squibb Net Income, 2016-2020 (USD Million)
Table 157: Bristol-Myers Squibb Sales Revenue Split, By Business Segment (%), FY2020
Table 158: Bristol-Myers Squibb Sales Revenue Split, By Geography Segment (%), FY2020
13.10 Boehringer Ingelheim
Table 159: Boehringer Ingelheim Revenues, 2016-2020 (USD Million)
Table 160: Boehringer Ingelheim Net Income/Loss, 2016-2020 (USD Million)
Table 161: Boehringer Ingelheim Sales Revenue Split, By Business Segment (%), FY2020
Table 162: Boehringer Ingelheim Sales Revenue Split, By Geography Segment (%), FY2020